Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Males and Females, ages 15 years ≥ of age (Except where local regulations and/or institutional policies do not allow for subjects \< 18 years of age to participate)
Subjects must have been diagnosed with stage III or/and stage IV histologically confirmed melanoma that is unresectable or metastatic
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
Subjects have not been treated by systemic anticancer therapy for unresectable or metastatic melanoma
You may not be if
Subjects with active brain metastases or leptomeningeal metastases
Subjects with ocular melanoma
Subjects with active, known or suspected autoimmune disease
Clareo Health | A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma
